The LIFTMOR Trial: High-Intensity Resistance Training Improves Bone Density in Postmenopausal Women
A randomized controlled trial showed that brief, supervised high-intensity resistance training improved lumbar spine BMD by nearly 3% in postmenopausal women with low bone mass.
Read the original article at Journal of Bone and Mineral ResearchKairos™'s Take
Kairos™'s perspective on this story
The LIFTMOR trial, published in the Journal of Bone and Mineral Research in 2018, challenged a longstanding clinical assumption: that postmenopausal women with osteopenia or osteoporosis should avoid high-intensity exercise. The trial randomized 101 postmenopausal women with low bone mass (T-score below -1.0) to either eight months of twice-weekly, 30-minute supervised high-intensity resistance and impact training (HiRIT) or a home-based low-intensity exercise program. The HiRIT group performed heavy compound lifts — deadlifts, squats, and overhead press — at loads exceeding 85% of their one-repetition maximum, plus impact loading through jumping chin-ups.
The results were striking. The HiRIT group gained 2.9% in lumbar spine bone mineral density while the control group lost 1.2% — a net difference of over 4%. Femoral neck density improved modestly in the HiRIT group while declining in controls. Critically, adherence was above 90% and there were no serious adverse events, demonstrating that properly supervised heavy loading is both safe and effective in this population.
Why This Matters for Midlife Health
Most exercise guidance for bone health has historically been vague: "do weight-bearing exercise." LIFTMOR showed that intensity matters. Light walking and gentle stretching did not produce the same stimulus. For women in midlife who are navigating hormonal changes and their downstream effects on bone, this study provides evidence that structured, progressive resistance training can meaningfully improve bone density — not just slow its decline. That is a critical distinction when the goal is prevention rather than damage control.
The Tracking Connection
Exercise interventions work best when they are tracked, progressive, and consistent. Kairos™ enables users to log their physical activity alongside bone health metrics and symptom tracking, creating a complete picture of how lifestyle interventions interact with hormonal health. When your next DXA scan shows improvement, you want to know what you were doing in the months before — and whether that aligns with the evidence. That is what longitudinal tracking delivers.
Ready to start tracking?
Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.
Get StartedMore from the newsroom
SWAN Study: Bone Loss Accelerates Sharply During the Menopause Transition
The landmark SWAN longitudinal study showed that bone mineral density remains stable in early perimenopause but declines sharply in late perimenopause — about 2% per year — continuing into early postmenopause.
The FREEDOM Trial: Denosumab Reduces Vertebral Fractures by 68% in Postmenopausal Women
The landmark FREEDOM trial published in NEJM showed that denosumab, a monoclonal antibody, significantly reduced vertebral, hip, and nonvertebral fractures in women with osteoporosis over 3 years.
The Treatment Gap in Osteoporosis: Fewer Than 20% of High-Risk Patients Receive Care
A comprehensive review documents the growing osteoporosis treatment gap — with diagnosis rates below 20% and post-fracture treatment rates declining despite effective therapies being available.